Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.
van Dijk, F
van Leeuwen, EM
van Duijn, CM
Nature Publishing Group
MetadataShow full item record
Iotchkova, V., Huang, J., Morris, J., Jain, D., Barbieri, C., Walter, K., Min, J., et al. (2016). Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.. Nature Genetics, 48 (11), 1303-1312. https://doi.org/10.1038/ng.3668
Large-scale whole-genome sequence data sets offer novel opportunities to identify genetic variation underlying human traits. Here we apply genotype imputation based on whole-genome sequence data from the UK10K and 1000 Genomes Project into 35,981 study participants of European ancestry, followed by association analysis with 20 quantitative cardiometabolic and hematological traits. We describe 17 new associations, including 6 rare (minor allele frequency (MAF) < 1%) or low-frequency (1% < MAF < 5%) variants with platelet count (PLT), red blood cell indices (MCH and MCV) and HDL cholesterol. Applying fine-mapping analysis to 233 known and new loci associated with the 20 traits, we resolve the associations of 59 loci to credible sets of 20 or fewer variants and describe trait enrichments within regions of predicted regulatory function. These findings improve understanding of the allelic architecture of risk factors for cardiometabolic and hematological diseases and provide additional functional insights with the identification of potentially novel biological targets.
This study makes use of data generated by the UK10K Consortium, derived from samples from the ALSPAC and TwinsUK data sets. A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org/. Funding for UK10K was provided by the Wellcome Trust under award WT091310. The research of N.S. is supported by the Wellcome Trust (grants WT098051 and WT091310), the European Union Framework Programme 7 (EPIGENESYS grant 257082 and BLUEPRINT grant HEALTH-F5-2011-282510) and the National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or NHSBT. P.L.A. was supported by NHLBI R21 HL121422-02. A full list of grant support and acknowledgements can be found in the Supplementary Note and ref. 14.
EC FP7 NOE (257082)
Wellcome Trust (091310/Z/10/Z)
Medical Research Council (MC_U106179471)
British Heart Foundation (RG/08/014/24067)
British Heart Foundation (RG/13/13/30194)
External DOI: https://doi.org/10.1038/ng.3668
This record's URL: https://www.repository.cam.ac.uk/handle/1810/264761